X0508 4 2023-10-02 0 0000827871 EAGLE PHARMACEUTICALS, INC. EGRX 0001469124 Tarriff Scott C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BLVD., SUITE 315 WOODCLIFF LAKE NJ 07677 1 1 1 0 CEO 1 Common Stock 2023-10-02 4 S 0 9511 15.23 D 577800 D Common Stock 2023-10-03 4 S 0 10024 14.41 D 567776 D Common Stock 2023-10-03 4 S 0 710 15.11 D 567066 D Common Stock 992623 I By Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016 These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.035 to $15.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.09 to $15.05 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.09 to $15.18 inclusive. The shares are held by the Trust for the benefit of the Reporting Person's spouse and children. The Reporting Person does not have investment control over the shares held by the Trust and disclaims beneficial ownership of the shares, except to any pecuniary interest therein, if any. /s/ Scott Tarriff 2023-10-04